NON-SMALL CELL LUNG CARCINOMA (NSCLC)
Clinical trials for NON-SMALL CELL LUNG CARCINOMA (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CARCINOMA (NSCLC) trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CARCINOMA (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Head-to-Head trial: new drug challenges leading lung cancer treatment
Disease control Recruiting nowThis study aims to see if a new drug called SCTB14 works better than the standard drug pembrolizumab (Keytruda) for people with a specific type of advanced lung cancer. It will involve 246 adults who have not yet received treatment for their cancer. The main goal is to see if SCT…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA (NSCLC)
Phase: PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Do lower chemo doses shorten lives of elderly cancer patients?
Disease control Recruiting nowThis study looks back at treatment records to see if giving older lung cancer patients reduced chemotherapy doses affects how long they live. Researchers will compare survival times between patients who received standard doses and those who received lower doses. The study involve…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA (NSCLC)
Sponsor: University of Malaya • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC